Luke O’Neill joins Pat Kenny fresh from a major biomedical conference in Oxford, where he met the scientists behind Ozempic and Mounjaro and heard the latest eye-opening data.
New GLP-1 drugs: more power, fewer side effects
Luke O’Neill joins Pat Kenny fresh from a major biomedical conference in Oxford, where he met the...
11.00 5 Sep 2026